These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 5472868)

  • 1. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 2. Uptake and storage of catecholamines in rabbit brain after chronic reserpine treatment.
    Dahlström A; Fuxe K; Hamberger B; Hökfelt T
    J Pharm Pharmacol; 1967 Jun; 19(6):345-9. PubMed ID: 4382362
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons.
    Lichtensteiger W; Langemann H
    J Pharmacol Exp Ther; 1966 Mar; 151(3):400-8. PubMed ID: 5938477
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of inhibition of catecholamine synthesis on dexamphetamine induced central stimulation.
    Svensson TH
    Eur J Pharmacol; 1970 Oct; 12(2):161-6. PubMed ID: 5472870
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical determination of neurotransmitter distribution.
    Hökfelt TG; Ljungdahl AS
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():1-24. PubMed ID: 4404674
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
    Segal M; Deneau GA; Seevers MH
    Neuropharmacology; 1972 Mar; 11(2):211-22. PubMed ID: 4623661
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin.
    Bak IJ; Hassler R; Kim JS
    Z Zellforsch Mikrosk Anat; 1969; 101(3):448-62. PubMed ID: 5362847
    [No Abstract]   [Full Text] [Related]  

  • 10. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid method for the simultaneous determination of noradrenaline, dopamine and 5HT in small samples of brain tissue.
    Metcalf G
    Anal Biochem; 1974 Jan; 57(1):316-20. PubMed ID: 4817509
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 13. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 14. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 15. Biogenic amines in discrete brain areas after treatment with monoamineoxidase inhibitors.
    Valzelli L; Garattini S
    J Neurochem; 1968 Mar; 15(3):259-61. PubMed ID: 5638622
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 17. Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.
    Hidaka H
    Nature; 1971 May; 231(5297):54-5. PubMed ID: 4930475
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 19. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.
    Taylor KM; Clark DW; Laverty R; Phelan EL
    Nat New Biol; 1972 Oct; 239(95):247-8. PubMed ID: 4507808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.